Industry Symposium Supported by Pfizer: A road map for integration of treatment of Relapsed and Refractory Multiple Myeloma in the community: harnessing the power of BCMA Bispecific Antibodies – A Blueprint for Academic and Community Collaboration

Chair(s)

• 

  Andrew Yee, MD

  Assistant Professor of Medicine
  Massachusetts General Hospital Cancer Center
  Boston, Massachusetts

Presentations:

• 08:00 - 08:05 East Coast USA Time

  Welcome and Introductions
  

  Speaker: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center
• 08:05 - 08:20 East Coast USA Time

  Bringing Innovative Therapies to the Point of Care: BCMA BsAbs in Relapsed and Refractory Multiple Myeloma
  

  Speaker: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center
• 08:20 - 08:30 East Coast USA Time

  Clinical Considerations on Safety When Using BCMA BsAbs
  

  Speaker: Albert Oriol, PhD (he/him/his) – Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
• 08:30 - 08:40 East Coast USA Time

  Perspectives on Community Use of BCMA BsAbs: Expanding Access to Novel Therapies
  

  Speaker: Janet A. MacEachern, MD FRCPC – Waterloo Regional Health Network

  Speaker: Arlene A. Gayle, MD (she/her/hers) – AdventHealth Medical Group